Both in Pharmaceuticals
AnaptysBio vs Kardigan
Over the past year ANAB returned −13.5% and KARD returned −29.6%; their daily moves had a correlation of 0.52.
ANAB −13.5% KARD −29.6%Growth of $1, one year, split-adjusted
| Metric | ANAB | KARD |
|---|---|---|
| Price | $46.61 | $13.03 |
| Market cap | $1.39B | $1.22B |
| Today | −4.31% | −6.12% |
| 1 month | −15.3% | −21.9% |
| 6 months | −31.0% | — |
| Year to date | −3.9% | — |
| 1 year | +35.9% | — |
| Revenue growth (YoY) | −8.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −206.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.0× | — |
| Net cash | $286.5M | $597.6M |
| Dividend yield | — | — |
| Volatility (60d) | 36.4% | — |
| Short % of float | 30.0% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).